106 related articles for article (PubMed ID: 9470818)
1. Expression of syndecan-1 in human B cell chronic lymphocytic leukaemia.
Sebestyén A; Kovalszky I; Mihalik R; Gallai M; Bocsi J; László E; Benedek S; Sréter L; Kopper L
Eur J Cancer; 1997 Nov; 33(13):2273-7. PubMed ID: 9470818
[TBL] [Abstract][Full Text] [Related]
2. Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia.
Wołowiec D; Dybko J; Wróbel T; Urbaniak-Kujda D; Jaźwiec B; Tomaszewska-Toporska B; Kapelko-Słowik K; Potoczek S; Kuliczkowski K
Mediators Inflamm; 2006; 2006(3):42394. PubMed ID: 16951490
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of syndecan expression by osteosarcoma cell lines in response to cytokines but not osteotropic hormones.
Birch MA; Skerry TM
Bone; 1999 Jun; 24(6):571-8. PubMed ID: 10375199
[TBL] [Abstract][Full Text] [Related]
4. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
5. Expression of syndecans, a heparan sulfate proteoglycan, in malignant gliomas: participation of nuclear factor-kappaB in upregulation of syndecan-1 expression.
Watanabe A; Mabuchi T; Satoh E; Furuya K; Zhang L; Maeda S; Naganuma H
J Neurooncol; 2006 Mar; 77(1):25-32. PubMed ID: 16132527
[TBL] [Abstract][Full Text] [Related]
6. Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas.
Sebestyén A; Berczi L; Mihalik R; Paku S; Matolcsy A; Kopper L
Br J Haematol; 1999 Feb; 104(2):412-9. PubMed ID: 10050727
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer.
Fujiya M; Watari J; Ashida T; Honda M; Tanabe H; Fujiki T; Saitoh Y; Kohgo Y
Jpn J Cancer Res; 2001 Oct; 92(10):1074-81. PubMed ID: 11676858
[TBL] [Abstract][Full Text] [Related]
8. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
[TBL] [Abstract][Full Text] [Related]
9. Syndecans and the lymphoid system.
Kopper L; Sebestyén A
Leuk Lymphoma; 2000 Jul; 38(3-4):271-81. PubMed ID: 10830734
[TBL] [Abstract][Full Text] [Related]
10. Growth factors and cytokines modulate gene expression of cell-surface proteoglycans in human periodontal ligament cells.
Worapamorn W; Haase HR; Li H; Bartold PM
J Cell Physiol; 2001 Mar; 186(3):448-56. PubMed ID: 11169984
[TBL] [Abstract][Full Text] [Related]
11. Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.
Mikami S; Ohashi K; Usui Y; Nemoto T; Katsube K; Yanagishita M; Nakajima M; Nakamura K; Koike M
Jpn J Cancer Res; 2001 Oct; 92(10):1062-73. PubMed ID: 11676857
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 regulates expression of the syndecan-1 proteoglycan on B lymphoid cells.
Sneed TB; Stanley DJ; Young LA; Sanderson RD
Cell Immunol; 1994 Feb; 153(2):456-67. PubMed ID: 8118875
[TBL] [Abstract][Full Text] [Related]
13. Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemia.
Witzig TE; Kimlinger T; Stenson M; Therneau T
Leuk Lymphoma; 1998 Sep; 31(1-2):167-75. PubMed ID: 9720726
[TBL] [Abstract][Full Text] [Related]
14. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
15. High syndecan-1 expression in breast carcinoma is related to an aggressive phenotype and to poorer prognosis.
Barbareschi M; Maisonneuve P; Aldovini D; Cangi MG; Pecciarini L; Angelo Mauri F; Veronese S; Caffo O; Lucenti A; Palma PD; Galligioni E; Doglioni C
Cancer; 2003 Aug; 98(3):474-83. PubMed ID: 12879463
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes from patients with early stage of B-cell chronic lymphocytic leukaemia and long survival synthesize decorin.
Campo S; Campo GM; Avenoso A; D'Ascola A; Musolino C; Calabrò L; Bellomo G; Quartarone E; Calatroni A
Biochimie; 2006 Dec; 88(12):1933-9. PubMed ID: 16938379
[TBL] [Abstract][Full Text] [Related]
17. Modulated glycosylation of proteoglycans during differentiation of human B lymphocytes.
Engelmann S; Ebeling O; Schwartz-Albiez R
Biochim Biophys Acta; 1995 May; 1267(1):6-14. PubMed ID: 7779869
[TBL] [Abstract][Full Text] [Related]
18. Serum syndecan-1, basic fibroblast growth factor and osteoprotegerin in myeloma patients at diagnosis and during the course of the disease.
Kyrtsonis MC; Vassilakopoulos TP; Siakantaris MP; Kokoris SI; Gribabis DA; Dimopoulou MN; Angelopoulou MK; Pangalis GA
Eur J Haematol; 2004 Apr; 72(4):252-8. PubMed ID: 15089762
[TBL] [Abstract][Full Text] [Related]
19. Search for genes responsible for UV susceptibility of human cells: involvement of syndecan-1 in UV resistance.
Kikuno K; Kita K; Nomura J; Hiwasa T; Yonemitsu H; Suzuki N
Biochem Biophys Res Commun; 1998 Dec; 253(2):519-23. PubMed ID: 9878568
[TBL] [Abstract][Full Text] [Related]
20. Expression of the cell-surface heparan sulfate proteoglycan mRNA in monkey submandibular gland.
Yamagata E; Kamada A
J Osaka Dent Univ; 1999 Oct; 33(2):83-7. PubMed ID: 10863479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
